Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Sales | 135 | 88 | 97 | 74 | 29 |
| Gross Profit | 180 | 110 | 150 | 100 | 20 |
| Operating Expenses | 3,360 | 2,820 | 2,560 | 1,920 | 1,300 |
| Operating Income | -3,225 | -2,732 | -2,463 | -1,846 | -1,271 |
| Other Income | 35 | 62 | -287 | 26 | -1,559 |
| Pre-tax Income | -3,190 | -2,670 | -2,750 | -1,820 | -2,830 |
| Income Tax | -1 | 1 | 30 | 0 | -1 |
| Net Income Continuous | -2,359 | -2,017 | -1,298 | -1,324 | -2,832 |
| Net Income | $-2,359 | $-2,017 | $-1,298 | $-1,324 | $-2,832 |
| EPS Basic Total Ops | -0.76 | -0.66 | -0.47 | -0.47 | -1.23 |
| EPS Basic Continuous Ops | -0.77 | -0.70 | -0.44 | -0.48 | -1.22 |
| EPS Diluted Total Ops | -0.76 | -0.66 | -0.47 | -0.47 | -1.23 |
| EPS Diluted Continuous Ops | -0.77 | -0.70 | -0.44 | -0.48 | -1.22 |
| EBITDA(a) | $-3,035 | $-2,562 | $-1,963 | $-1,796 | $-1,311 |